Houston-based medical device firm Nexalin Technology, Inc. is pioneering neurostimulation products to help manage mental health disorders in the United States and China. Their Nexalin Device offers a unique drug-free therapy that emits a specially designed frequency-based waveform to encourage a positive response from mid-brain structures associated with conditions such as anxiety and insomnia. Nexalin Technology has also developed Generation 2 and 3 medical devices that are currently undergoing clinical trials for treating substance abuse issues linked to opiate, cocaine, alcohol abuse, Alzheimer’s disease, and dementia.
Nuix's ticker is NXL
The company's shares trade on the ASX stock exchange
They are based in Sydney, Australia
There are 201-500 employees working at Nuix
It is nuix.com
Nuix is in the Technology sector